University of Nebraska Medical Center ( Site 1053) — Omaha, Nebraska

University of Nebraska Medical Center ( Site 1053) is a clinical research site located in Omaha, Nebraska, United States 68105.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

University of Nebraska Medical Center ( Site 1053) has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Pulmonary Arterial Hypertension, Hypertension, Pulmonary.

Sponsors: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Nebraska Medical Center ( Site 1053)?

University of Nebraska Medical Center ( Site 1053) has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Nebraska Medical Center ( Site 1053) conducted?

University of Nebraska Medical Center ( Site 1053) has 2 clinical trials on record, with 1 currently active. Their work covers Pulmonary Arterial Hypertension, Hypertension, Pulmonary.

Is University of Nebraska Medical Center ( Site 1053) accredited by Crixeo Health?

University of Nebraska Medical Center ( Site 1053) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Nebraska Medical Center ( Site 1053)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.